Advertisement

 

 

A comparative study of CIDP in a cohort of HIV-infected and HIV-uninfected patients.

A comparative study of CIDP in a cohort of HIV-infected and HIV-uninfected patients.
Author Information (click to view)

Moodley K, Bill PL, Patel VB,


Moodley K, Bill PL, Patel VB, (click to view)

Moodley K, Bill PL, Patel VB,

Advertisement

Neurology(R) neuroimmunology & neuroinflammation 2016 12 154(2) e315 doi 10.1212/NXI.0000000000000315

Abstract
OBJECTIVE
To investigate differences in clinical presentation, electrodiagnostic measures, CSF changes, and treatment outcome measures in HIV-infected and HIV-uninfected patients with chronic inflammatory demyelinating polyneuropathy (CIDP).

METHODS
A retrospective analysis of medical records of all patients meeting the European Federation of Neurology diagnostic criteria for idiopathic CIDP was performed in 2 neuromuscular units in Kwa-Zulu Natal between 2003 and 2015.

RESULTS
Eighty-four patients were included in the study; 39 were HIV-infected and 45 were HIV-uninfected. Among the HIV-infected patients, the majority were younger, were female, and had a monophasic progressive illness. Eighty-six percent (86%) were corticosteroid-responsive and 76% were in remission within 6-12 months requiring no further treatment. Among the HIV- uninfected patients, the majority were older, were male, and had a relapsing-remitting course. Twenty-seven percent (27%) were corticosteroid-responsive, 95% required combination therapy, and 33% were not in remission by 18 months on therapy.

CONCLUSION
This study shows that HIV-infected patients with CIDP were younger, were more often female, displayed a monophasic progressive course, were highly steroid-responsive, and went into remission within 12 months of corticosteroid initiation.

Submit a Comment

Your email address will not be published. Required fields are marked *

one × two =

[ HIDE/SHOW ]